Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692451
What this trial is testing
Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting
Who this might be right for
Nausea and Vomiting Induced by Antibody-drug Conjugates (ADCs)
Peking University Cancer Hospital & Institute 124